A decade later, the mortality rate was 126.8 per 100,000.
This improvement, attributed mainly to earlier diagnosis and better treatment, is reflected in the increasing survival rate for lung cancer, still the leading cause of cancer deaths.
The Northern Cancer Network's clinical director, Dr Richard Sullivan, of Auckland City Hospital, said the Auckland-Northland region's lung cancer survival rate was now 15 per cent of patients five years after diagnosis.
Two years ago it was 10 per cent.
Dr Sullivan said the five-year survival rates in Australia and Canada were 17 to nearly 20 per cent.
New systems, efforts to shorten waiting times, PET scanning of patients before curative therapy was attempted and new therapies were all improving the care of lung cancer patients, he said.
The state medicines funding agency Pharmac will next month start paying for patients in the advanced stages of a common type of lung cancer - non-squamous, non-small-cell - to be treated with Iressa, a targeted treatment. But patients will be eligible only if their cancer cells test positive for a mutation that indicates the drug is likely to help.
The ministry report shows that when compared to the national rate for cancer registration, three health districts - Bay of Plenty, Taranaki and Canterbury - had a higher rate. Three - Counties Manukau, Otago and Southland - had a lower rate.
Cancer mortality rates were higher than average in Northland, Waikato, Lakes, Taranaki, Wanganui and Tairawhiti. They were lower in Waitemata, Nelson Marlborough and Canterbury, and not significantly different elsewhere.